IntegriChain Resource Center

Find helpful resources and opportunities to learn more about our big data insights for distribution, pharmacy, and payer management.

Webinars

Introducing the IntegriChain Summer Release –Collaborative Actionable Insight Discovery and Intuitive Business Intelligence Development

bg-icon-demand-visibilityThis webinar introduces you to our summer release, which expands IntegriChain’s custom visualization and analytics suite for life sciences channel data and analytics. Learn how this new release for Demand Visibility and Builder delivers collaborative actionable insight discovery and intuitive business intelligence of the downstream channel for life sciences manufacturers.
Watch the Webinar

 

Unlock the Power of Scorecard Analytics to Maximize Pay-for-Performance

integrichain scorecardThis webinar covers a major enhancements to IntegriChain Scorecard, unlocking the power of Scorecard data with robust data analysis and visualization capabilities. This enhancement allows Scorecard users to utilize their robust Scorecard data to further maximize pay-for-performance by analyzing channel investment against performance through IntegriChain’s powerful query and reporting tools.
Watch Webinar

 

Using Channel Data Analytics for 340B Monitoring and Audit SupportINT_340B_webinar_200x200
This webinar covers the changing breadth of the 340B Discount Drug Program and the insights offered in the Health Resources and Services Administration’s (HRSA’s) recently released mega-guidance, including results of its program-integrity audits. In addition, the webinar  addresses how pharmaceutical manufacturers can utilize channel data analytics to drive monitoring and auditing of their 340B programs.
Watch Webinar

IntegriChain Builder

Introducing New IntegriChain Builder Business Intelligence Tool
IntegriChain Builder radically improves the actionability of channel analytics, driving down the cost of total ownership of wholesaler and specialty data sources while maximizing the value of manufacturer investments in data agreements. In this webinar, you will learn how you can:

  • Merge disparate data sources into one report or visualization
  • Explore data logically, intuitively, and meaningfully
  • Manipulate extracted data using custom calculations
  • Build custom reports, charts, and visualizations
  • Share reports with internal stakeholders
  • Export reports to .pdf or .ppt for communication with senior management

Watch Webinar

 

The Impact of Downstream Inventory on Gross-to-Net Accounting
benefits-icon-builder_savemoneyLearn more about best practices for estimating inventory when calculating gross-to-net to eliminate gross overstatements or understatements of pipeline liabilities that do not triangulate well with other channel commerce data sets. We will focus on real-world methodologies to avoid error risk in estimating the impact of downstream inventory on gross-to-net. In this webinar, you will learn about best practices for using auditor-approved downstream inventory data and analytics for preparing for loss of exclusivity (LOE), tightening gross-to-net reserves, and improving visibility to gross sales forecast risk.
Watch Webinar


ebooks

G2N ebook thumbnail

The Impact of Downstream Inventory on Gross-to-Net Accounting
Learn more about best practices for de-risking the process of estimating inventory when calculating gross-to-net to eliminate gross overstatements or understatements of pipeline liabilities that do not triangulate well with other channel commerce data sets. We focus on real-world methodologies to avoid error risk in estimating the impact of downstream inventory on gross-to-net, including best practices for using auditor-approved downstream inventory data and analytics for preparing for loss of exclusivity (LOE), tightening gross-to-net reserves, and improving visibility to gross sales forecast risk. 
Download Now

 

ebook-mobile-optimized-channel

The IntegriChain Cloud: Mobile-Optimized Channel Management and Demand Sensing Analytics
The latest release of the IntegriChain channel management cloud offers mobile user access and near real-time demand sensing to maximize the accessibility and value of channel data through the life sciences supplier enterprise. Check out this ebook that walks you through all of the exciting new features now available in the IntegriChain Cloud.
Download Now

 

ebook-daily-business-mgmt

Daily Business Management ebook
In today’s era of Pay for Performance agreements and lower channel inventory, pharmaceutical manufacturers want to know how to better align product availability with the overall cost of distribution. The answer can be found in a new approach to trade data utilization called Daily Business Management. Download the Daily Business Management ebook to learn about the next evolution in channel agreements.
Download Now

 

ebook-downstream-data

Leaving the Legacy ebook
Pharmaceutical manufacturers continue to struggle with ensuring product availability, controlling distribution cost, and increasing forecast accuracy. This is often because they are using outdated or constrained legacy platforms. Download the Leaving the Legacy ebook to learn how three of our customers moved away from disparate systems to IntegriChain’s informed applications and transformed their businesses with actionable channel data.
Download Now


Webcasts

webcast order is not an order

“Outside In” Order Management Webcast with Supply Chain Insights
Many companies today are handling their orders from an “inside out” approach rather than taking actual channel data to make informed order decisions. This new “outside in” methodology ultimately helps to advance inventory turns and improves operating margins. In this webcast, Lora Cecere, Founder & CEO of Supply Chain Insights, focuses on how suppliers can use advanced analytics to sense order flows and yield exceptions to drive a better supply chain response.
Watch Webcast


White Papers

white paper value of the one percent

Value of 1% White Paper
Manufacturers know that ensuring product availability is very difficult, especially when product distribution is so expensive. Further complicating matters, sales do not equal demand, leading to a real commerce optimization problem within the demand network. Download The Value of 1% White Paper to explore how you can optimize demand network commerce with informed applications.
Download Now

 

white paper daily business management

Daily Business Management White Paper
In today’s era of Pay for Performance agreements and lower channel inventory, pharmaceutical manufacturers want to know how to better align product availability with the overall cost of distribution. The answer can be found in a new approach to trade data utilization called Daily Business Management. Download the Daily Business Management White Paper to learn about the next evolution in channel agreements.
Download Now


Published Articles

pharmaceutical-commerce-weiss

Pharmaceutical Commerce – Use Data Analytics to Monitor 340B Discount Drug Pricing
Dave Weiss, Executive Director, Center of Excellence
340B subject matter expert Dave Weiss deep dives into how data analytics can be used to monitor 340B discount drug pricing.
Read the article

 

pharmaceutical-commerce-john-still

Pharmaceutical Commerce – Finding the Value in Outsourced Contract Management Services
John Still, Executive Director, Services, PharmaMetrics
The growing complexity of managed-markets contract support makes outsourcing a near-necessity for Small Pharma, and a better option for Big Pharma.
Read the article

 

pharmaceutical-executive-still-carlson

Pharmaceutical Executive – How Not to Handle Rebates
John Still, Executive Director, Services, PharmaMetrics
David Carlson, Segment Lead-Payer & Market Access, PharmaMetrics
As financial pressures increase, pharmaceutical companies are paying greater attention to cutting costs and increasing efficiency…Yet rebate expenditures continue to expand.
Read the article

 

medicare-negotiations-drug-pricing-carlson

Debates on U.S. Healthcare –Medicare Negotiations of Drug Pricing
David Carlson, Segment Lead-Payer & Market Access, PharmaMetrics
David takes a look at the implications of the Affordable Healthcare Act on Medicare negotiations on drug pricing.
Read the article